Skip to main content
TLSI filings

Corporate insider profile

David Patience Filing Activity

Latest reported as Chief Financial Officer of TriSalus Life Sciences, Inc. (TLSI).

Purchase filings
1
Reported companies
1
Net open-market value
$17,253
Latest transaction
May 15, 2026

Affiliated corporations

Reported company relationships

Transaction history

Open-market Transactions

Open-market insider purchase and sale transactions
DateCompanyRoleTypeSharesPriceTotal value
May 15, 2026TriSalus Life Sciences, Inc. (TLSI)Chief Financial OfficerOpen Market Purchase7,100$2.43$17,253